HeartBeam (BEAT) Stock Forecast, Price Target & Predictions

OverviewOwnership Financials Chart Transcripts

BEAT Stock Forecast

HeartBeam stock forecast is as follows: an average price target of $10.00 (represents a 258.42% upside from BEAT’s last price of $2.79) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.

BEAT Price Target

The average price target for HeartBeam (BEAT) is $10.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $10.00 to $10.00. This represents a potential 258.42% upside from BEAT's last price of $2.79.

BEAT Analyst Ratings

Buy

According to 1 Wall Street analysts, HeartBeam's rating consensus is 'Buy'. The analyst rating breakdown for BEAT stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

HeartBeam Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Dec 02, 2022		Industrial Alliance Securities	-	-	132.17%	258.42%

Row per page

Go to

The latest HeartBeam stock forecast, released on Dec 02, 2022 by Industrial Alliance Securities company, set a price target of $10.00, which represents a 132.17% increase from the stock price at the time of the forecast ($4.31), and a 258.42% increase from BEAT last price ($2.79).

HeartBeam Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	-
Avg Price Target	-	-	-
Last Closing Price	$2.79	$2.79	$2.79
Upside/Downside	-100.00%	-100.00%	-100.00%

In the current month, the average price target of HeartBeam stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to HeartBeam's last price of $2.79. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Dec 02, 2022	Alliance Global Partners		Buy	Initialise

Row per page

Go to

HeartBeam's last stock rating was published by Alliance Global Partners on Dec 02, 2022. The company Initialise its BEAT rating from "null" to "Buy".

HeartBeam Financial Forecast

HeartBeam Revenue Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Dec 22	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15	Jun 14	Sep 13	Mar 12	Mar 11	Mar 10	Mar 09
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$113.03M	$103.98M	$94.50M	$55.88M	$48.64M	$43.44M	$42.65M	$31.87M	$27.05M	$34.00M	$31.82M	$35.72M
Avg Forecast	$4.40M	$3.40M	$2.60M	$2.00M	$1.50M	$1.10M	$800.00K	$500.00K	$3.48M	$2.67M	$100.00K	$50.00K	$37.50K	-	-	$250.00K	$40.00K	$123.24M	$108.01M	$101.50M	$71.18M	$55.88M	$24.32M	$14.48M	$21.32M	$5.31M	$29.50M	$57.12M	$40.65M	$35.72M
High Forecast	$4.40M	$3.40M	$2.60M	$2.00M	$1.50M	$1.10M	$800.00K	$500.00K	$3.48M	$2.67M	$100.00K	$50.00K	$37.50K	-	-	$250.00K	$40.00K	$147.88M	$129.61M	$121.80M	$85.42M	$67.06M	$29.18M	$17.37M	$25.59M	$6.37M	$35.40M	$68.54M	$48.78M	$42.86M
Low Forecast	$4.40M	$3.40M	$2.60M	$2.00M	$1.50M	$1.10M	$800.00K	$500.00K	$3.48M	$2.67M	$100.00K	$50.00K	$37.50K	-	-	$250.00K	$40.00K	$98.59M	$86.41M	$81.20M	$56.94M	$44.70M	$19.46M	$11.58M	$17.06M	$4.25M	$23.60M	$45.69M	$32.52M	$28.58M
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	-	-	2	3	12	11	13	18	13	10	18	19	12	16	17	8	10
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.05%	1.02%	1.33%	1.00%	2.00%	3.00%	2.00%	6.00%	0.92%	0.60%	0.78%	1.00%

HeartBeam's average Quarter revenue forecast for Dec 22 based on 12 analysts is $123.24M, with a low forecast of $98.59M, and a high forecast of $147.88M. BEAT's average Quarter revenue forecast represents a 9.03% increase compared to the company's last Quarter revenue of $113.03M (Mar 20).

HeartBeam EBITDA Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Dec 22	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15	Jun 14	Sep 13	Mar 12	Mar 11	Mar 10	Mar 09
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	-	-	2	3	12	11	13	18	13	10	18	19	12	16	17	8	10
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-4.11M	$-3.74M	$24.93M	$22.11M	$17.56M	$3.04M	$7.38M	$3.03M	$-746.00K	$800.00K	$-1.51M	$1.73M	$-2.35M	$1.29M
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$21.84M	$23.77M	$21.58M	$11.81M	$3.04M	$8.11M	$3.03M	$-820.60K	$2.88M	$-1.65M	$2.91M	$-3.01M	$857.33K
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$26.20M	$28.52M	$25.89M	$14.17M	$3.65M	$9.74M	$3.64M	$-656.48K	$3.46M	$-1.32M	$3.49M	$-2.40M	$1.03M
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$17.47M	$19.01M	$17.26M	$9.45M	$2.44M	$6.49M	$2.42M	$-984.72K	$2.30M	$-1.98M	$2.33M	$-3.61M	$685.87K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.17%	1.05%	1.03%	1.49%	1.00%	0.91%	1.00%	0.91%	0.28%	0.92%	0.60%	0.78%	1.50%

12 analysts predict BEAT's average Quarter EBITDA for Dec 22 to be $21.84M, with a high of $26.20M and a low of $17.47M. This is -12.40% lower than HeartBeam's previous annual EBITDA (Mar 20) of $24.93M.

HeartBeam Net Income Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Dec 22	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15	Jun 14	Sep 13	Mar 12	Mar 11	Mar 10	Mar 09
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	-	-	2	3	12	11	13	18	13	10	18	19	12	16	17	8	10
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-3.88M	$-3.66M	$7.11M	$11.69M	$5.98M	$196.00K	$3.97M	$-69.00K	$-3.99M	$-2.96M	$-3.53M	$-1.55M	$-5.43M	$-722.00K
Avg Forecast	$-18.46M	$-4.55M	$-4.55M	$-4.82M	$-4.82M	$-4.82M	$-4.82M	$-4.82M	$-2.81M	$-2.81M	$-4.28M	$-4.15M	$-5.08M	$-4.55M	$-4.38M	$-4.01M	$-3.30M	$1.73M	$6.78M	$11.40M	$4.02M	$196.00K	$4.37M	$-69.00K	$-4.39M	$-10.64M	$-3.86M	$-2.61M	$-6.94M	$-481.33K
High Forecast	$-18.46M	$-4.55M	$-4.55M	$-4.82M	$-4.82M	$-4.82M	$-4.82M	$-4.82M	$-2.81M	$-2.81M	$-4.28M	$-4.01M	$-5.08M	$-4.55M	$-4.38M	$-4.01M	$-3.30M	$2.08M	$8.13M	$13.68M	$4.83M	$235.20K	$5.24M	$-55.20K	$-3.51M	$-8.51M	$-3.08M	$-2.09M	$-5.55M	$-385.07K
Low Forecast	$-18.46M	$-4.55M	$-4.55M	$-4.82M	$-4.82M	$-4.82M	$-4.82M	$-4.82M	$-2.81M	$-2.81M	$-4.28M	$-4.28M	$-5.08M	$-4.55M	$-4.38M	$-4.01M	$-3.30M	$1.39M	$5.42M	$9.12M	$3.22M	$156.80K	$3.49M	$-82.80K	$-5.26M	$-12.77M	$-4.63M	$-3.13M	$-8.33M	$-577.60K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.18%	-2.11%	1.05%	1.02%	1.49%	1.00%	0.91%	1.00%	0.91%	0.28%	0.92%	0.60%	0.78%	1.50%

HeartBeam's average Quarter net income forecast for Dec 22 is $1.73M, with a range of $1.39M to $2.08M. BEAT's average Quarter net income forecast represents a -75.61% decrease compared to the company's last Quarter net income of $7.11M (Mar 20).

HeartBeam SG&A Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Dec 22	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15	Jun 14	Sep 13	Mar 12	Mar 11	Mar 10	Mar 09
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	-	-	2	3	12	11	13	18	13	10	18	19	12	16	17	8	10
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.10M	$2.10M	$45.33M	$41.02M	$39.29M	$24.78M	$20.05M	$18.59M	$18.43M	$15.67M	$14.82M	$17.74M	$17.67M	$21.87M
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$49.62M	$43.22M	$40.02M	$26.42M	$24.78M	$22.05M	-	$20.28M	-	$16.17M	$29.80M	$22.58M	$14.58M
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$59.54M	$51.86M	$48.02M	$31.70M	$29.73M	$26.46M	-	$24.33M	-	$19.41M	$35.76M	$27.10M	$17.50M
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$39.69M	$34.58M	$32.01M	$21.13M	$19.82M	$17.64M	-	$16.22M	-	$12.94M	$23.84M	$18.07M	$11.67M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.04%	1.05%	1.03%	1.49%	1.00%	0.91%	-	0.91%	-	0.92%	0.60%	0.78%	1.50%

HeartBeam's average Quarter SG&A projection for Mar 24 is -, based on 2 Wall Street analysts, with a range of - to -. The forecast indicates a -100.00% fall compared to BEAT last annual SG&A of $2.10M (Dec 23).

HeartBeam EPS Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Dec 22	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15	Jun 14	Sep 13	Mar 12	Mar 11	Mar 10	Mar 09
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	-	-	2	3	12	11	13	18	13	10	18	19	12	16	17	8	10
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.15	$-0.45	$0.21	$0.35	$0.18	$0.01	$0.15	$-0.00	$-0.15	$-0.12	$-0.14	$-0.06	$-0.23	$-0.03
Avg Forecast	$-0.69	$-0.17	$-0.17	$-0.18	$-0.18	$-0.18	$-0.18	$-0.18	$-0.10	$-0.10	$-0.16	$-0.15	$-0.19	$-0.17	$-0.17	$-0.15	$-0.12	$-0.35	$0.41	$0.40	$0.15	$0.16	$0.11	$0.02	$0.01	$-0.07	$-0.12	$-0.25	$-0.23	$0.02
High Forecast	$-0.69	$-0.17	$-0.17	$-0.18	$-0.18	$-0.18	$-0.18	$-0.18	$-0.10	$-0.10	$-0.16	$-0.15	$-0.19	$-0.17	$-0.17	$-0.15	$-0.12	$-0.35	$0.49	$0.48	$0.19	$0.19	$0.13	$0.02	$0.01	$-0.06	$-0.10	$-0.20	$-0.18	$0.02
Low Forecast	$-0.69	$-0.17	$-0.17	$-0.18	$-0.18	$-0.18	$-0.18	$-0.18	$-0.10	$-0.10	$-0.16	$-0.16	$-0.19	$-0.17	$-0.17	$-0.15	$-0.12	$-0.35	$0.33	$0.32	$0.12	$0.13	$0.09	$0.02	$0.01	$-0.09	$-0.14	$-0.30	$-0.28	$0.02
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.22%	1.30%	0.51%	0.87%	1.20%	0.04%	1.36%	-0.13%	-15.00%	1.71%	1.17%	0.24%	1.00%	-1.50%

According to 12 Wall Street analysts, HeartBeam's projected average Quarter EPS for Dec 22 is $-0.35, with a low estimate of $-0.35 and a high estimate of $-0.35. This represents a -265.08% decrease compared to BEAT previous annual EPS of $0.21 (Mar 20).

HeartBeam Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
HLTH	Cue Health	-	-	19900.00%	Hold
BEAT	HeartBeam	-	-	258.42%	Buy
HCTI	Healthcare Triangle	-	-	83.49%	Buy
NUTX	Nutex Health	-	-	36.74%	Buy
UTRS	Minerva Surgical	-	-	-	Buy

BEAT Forecast FAQ

Is HeartBeam a good buy?

Yes, according to 1 Wall Street analysts, HeartBeam (BEAT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of BEAT's total ratings.

What is BEAT's price target?

HeartBeam (BEAT) average price target is $10 with a range of $10 to $10, implying a 258.42% from its last price of $2.79. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will HeartBeam stock go up soon?

According to Wall Street analysts' prediction for BEAT stock, the company can go up by 258.42% (from the last price of $2.79 to the average price target of $10), up by 258.42% based on the highest stock price target, and up by 258.42% based on the lowest stock price target.

Can HeartBeam stock reach $4?

BEAT's average twelve months analyst stock price target of $10 supports the claim that HeartBeam can reach $4 in the near future.

What are HeartBeam's analysts' financial forecasts?

HeartBeam's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $3.9M (high $3.9M, low $3.9M), average EBITDA is $0 (high $0, low $0), average net income is $-19.262M (high $-19.262M, low $-19.262M), average SG&A $0 (high $0, low $0), and average EPS is $-0.72 (high $-0.72, low $-0.72). BEAT's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $12.4M (high $12.4M, low $12.4M), average EBITDA is $0 (high $0, low $0), average net income is $-32.37M (high $-32.37M, low $-32.37M), average SG&A $0 (high $0, low $0), and average EPS is $-1.21 (high $-1.21, low $-1.21).

Did the BEAT's actual financial results beat the analysts' financial forecasts?

In terms of the last quarterly report (Mar 2020), HeartBeam's revenue was $113.03M, beating the average analysts' forecast of $108.01M by 4.65%. The company's EBITDA was $24.92M, beating the average prediction of $23.77M by 4.88%. HeartBeam's net income was $7.11M, beating the average estimation of $6.78M by 4.88%. The company's SG&A was $45.33M, beating the average forecast of $43.22M by 4.88%. Lastly, the company's EPS was $0.21, missing the average prediction of $0.41 by -48.78%